tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Gecina upgraded to Outperform from Neutral at Exane BNP Paribas

Exane BNP Paribas analyst Rob Jones upgraded Gecina to Outperform from Neutral with a EUR 120 price target. The analyst sees the stock as undervalued following the recent underperformance.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1